Blackstone’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Blackstone's GSK Position: Q2 2026 in Review
Blackstone reduced its GSK (GSK) stake by 61% in Q2 2026, selling an estimated $2.74M and leaving 33,172 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #192.
Blackstone first reported a position in GSK in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.69M in Q1 2026. 1,050 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Blackstone held 33,172 shares of GSK worth $1.74M as of Q2 2026.
- Blackstone sold 51,829 GSK shares in Q2 2026, an estimated $2.74M.
- GSK made up ﹤0.01% of Blackstone's portfolio in Q2 2026, its #192 holding.
- Blackstone first reported a position in GSK in Q1 2026 and has held it in 2 quarters since.
- Blackstone's GSK position peaked at $4.69M in Q1 2026.
- 1,050 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.